Careers  |  Sign In  |  Register

Higher Melatonin Levels May Prevent Prostate Cancer

A new study presented at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research may provide evidence that a disrupted circadian rhythm may be linked to prostate carcinogenesisThe Huffington Post reports. Researchers examined morning urine levels of 6-sulfatoxymelatonin, a metabolic by-product of melatonin, in 928 men and then looked to see how many men developed prostate cancer up to 7 years later. Researchers “found an association between having 6-sulfatoxymelatonin urine levels above the median level…and a 31% decreased risk of overall prostate cancer.” They also found that “men with higher 6-sulfatoxymelatonin levels had a 75% significantly reduced risk of advanced disease compared to men with lower levels.” Though the study is in its preliminary stages, the results suggest that getting a good nights sleep and proper regulation of melatonin may have anti-carcinogenic properties.

Read the article published by The Huffington Post.